You have read all your free articles, to continue reading subscribe to read the rest of this content.
A joint development 2 year-project, "TEHO adaptive clinical trial design – poised to accelerate approval" by University of Helsinki and University of Turku has been awarded with over 2 million Euros in the Challenge Finland competition. The TEHO project aims to develop a new, faster and more efAlready a subscriber…
Targovax announces that clinical trials investigating ONCOS-102 in the treatment of melanoma and mesothelioma have successfully passed their respective first, planned, independent safety reviews. The safety reviews of ONCOS-102 in the first four patients in the melanoma trial and first three patiAlready a subscriber Login You have read all your…
Moberg Pharma have announced that all patients in the European MOB-015 Phase 3 study have completed their last study visit. The data collection in the study were completed without any negative impact from COVID-19. The timeline remains unchanged with topline results expected by the end of the secAlready a subscriber…
Zealand Pharma and Beta Bionics announce a positive outcome from the Phase 2a clinical safety trial using dasiglucagon in the dualhormone artificial pancreas system, developed at Boston University and licensed to Beta Bionics. The study was conducted at the Massachusetts General Hospital DiabetesAlready a subscriber Login You have read all…
